Who needs labs and who needs statins? Comparative and cost effectiveness analyses of non-laboratory-based laboratory-based and staged primary cardiovascular disease screening guidelines

摘要

BackgroundEarly detection and treatment of cardiovascular disease (CVD) risk factors produces significant clinical benefits, but no consensus exists on optimal screening algorithms. This study aimed to evaluate the comparative and cost effectiveness of staged laboratory-based and non-laboratory-based total cardiovascular disease risk assessment.